Login | Help
Users of this system, can login to view this document.
Login
Enter the following information to request a copy of the document from the responsible person.
A PSA-activated protoxin (PRX302) administered transperineally to men with BPH is well tolerated and induces reduction in prostate volume and symptomatic relief